Product Information
JORNAY PM 60 MG CAPSULE is a brand product labeled by Ironshore Pharmaceuticals Inc., priced at $15.4019 per EA under NDC 71376020303. Its NADAC has been published 355 times since Dec 18, 2019.
FDA first approved this application on Aug 8, 2018.
The High Outlier badge above means this manufacturer's average price in the Methylphenidate Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Ironshore Pharmaceuticals Inc.NDC
71376020303
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA209311FDA Approved
8/8/2018
On Market Since
6/1/2019
Pharmacological Classes
Price Statistics
The NADAC for JORNAY PM 60 MG CAPSULE has been published 355 times since Dec 18, 2019, and over the history we have for it it has risen 29.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.4019 per EA |
|---|---|
| All-time high | $15.4236 (Jun 10, 2026) |
| All-time low | $11.7286 (Apr 22, 2020) |
| 52-week high | $15.4236 |
| 52-week low | $14.9647 |
| Median price | $13.9031 |
| Average price | $13.7509 |
| Largest weekly change | +6.1% (Aug 5, 2020) |
| Weeks tracked | 355 |
| Tracking since | Dec 18, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ironshore Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JORNAY PM 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for JORNAY PM 60 MG CAPSULE, manufactured by Ironshore Pharmaceuticals Inc., is $15.4019 per EA (NDC 71376020303), effective Sep 30, 2026.
How has the price of JORNAY PM 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for JORNAY PM 60 MG CAPSULE has risen 29.8%. It has been tracked across 355 weekly CMS publications since Dec 18, 2019.
What are the highest and lowest recorded NADAC prices for JORNAY PM 60 MG CAPSULE?
Since Dec 18, 2019, the NADAC for JORNAY PM 60 MG CAPSULE has ranged from a low of $11.7286 (Apr 22, 2020) to a high of $15.4236 (Jun 10, 2026), with a median of $13.9031 per EA.
Are there cheaper alternatives to JORNAY PM 60 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER(CD) 60 MG CP, is $1.8017 per EA — about 88% below JORNAY PM 60 MG CAPSULE.
Who manufactures JORNAY PM 60 MG CAPSULE?
JORNAY PM 60 MG CAPSULE (NDC 71376020303) is labeled by Ironshore Pharmaceuticals Inc., and CMS classifies it as a brand product.